DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
Materials from Clinical Study of the Biological Activity of Tsuverkalov Dysenterin
FOREIGN TECHNOLOGY DIV WRIGHT-PATTERSONAFB OH
Pagination or Media Count:
The sensitizing activity was studied of an allergen dysenterin following its intracutaneous administration. It was found that a diagnostic dose of the allergen containing 75-100 mcg of protein in 0.1 ml exerts a sensitizing effect. It is shown that decrease of the concentration by three times ensures a similar diagnostic result as compared with the initial concentration.
APPROVED FOR PUBLIC RELEASE